-+ 0.00%
-+ 0.00%
-+ 0.00%

Ministry of Natural Resources: The value added of the national marine medicine and functional products industry will reach 99.6 billion yuan in 2025

Zhitongcaijing·11/20/2026 07:17:05
Listen to the news

The Zhitong Finance App learned that on November 20, the Ministry of Natural Resources held a press conference to release the “National Marine Drugs and Functional Products Industry Development Report 2026” (hereinafter referred to as the “Report”). According to the “Report”, the value added of the national marine medicine and functional products industry increased from more than 30 billion yuan in 2012 to 99.6 billion yuan in 2025. During the “14th Five-Year Plan” period, industrial value added increased by 40%. Among them, industrial value added in 2025 increased by 6.1% over the previous year (calculated at constant prices). The industry is developing rapidly and growing well.

By the end of 2025, the marine pharmaceuticals and functional products industry will form a pattern where the three major marine economic circles are led by the east and followed by the north and south. China's marine microbial species storage scale and diversity are among the highest in the world, and the world's largest abyssal biological database has been built. The number of marine natural products discovered in China ranks first in the world. AI-assisted drug screening efficiency is more than 100 times higher than traditional ones, a historic breakthrough has been achieved in the number of new marine drugs approved for clinical trials. Many raw materials dominate global supply, and a number of specialty products occupy a high position in the value chain.

In terms of resource supply, China has further developed offshore biological resources, accelerated the development of offshore biological resources, and continued to improve its ability to explore and preserve deep-sea and polar marine living resources.

In terms of scientific and technological innovation, China's relevant scientific research projects have systematically supported key technology research and produced a large number of technological achievements. Several marine biomedical projects have received awards, and the number of invention patent applications and current standards continues to increase.

In terms of development results in key areas, China's marine innovative drug research and development has made systematic progress. Artificial intelligence has helped accelerate the entire drug development chain; clinical trial entry and process progress are being promoted simultaneously, and 8 new Class 1 drugs using marine organisms as pharmaceutical sources have obtained implied clinical trial permits; the “Pharmacopoeia of the People's Republic of China” (2025 edition) has been promulgated, and the development of traditional marine traditional Chinese medicine resources has deepened. As the supply of raw materials continues to expand, marine health foods are developing in the direction of convenience and optimization of absorption and utilization performance. The application areas cover anti-oxidation, improving bone density, maintaining blood lipid health, and increasing immunity, etc., and the market size is rapidly expanding. The production capacity scale of core raw materials for marine biological products in China ranks among the highest in the world. The application of marine biological manufacturing products continues to expand in the fields of medical materials, enzyme preparations, agricultural products, etc.

In terms of international cooperation, in 2025, the United Nations “Ocean Decade” Deep Sea Microbiome and Ecosystems (DOME) scientific program was officially established. The “Fuzhou University-National University of Singapore Joint Laboratory for International Cooperation on Marine Biological Products” was established. The China-ASEAN Marine Drugs and Biological Products Symposium was successfully held.

This article was edited by the Ministry of Natural Resources, Zhitong Finance Editor: Chen Wenfang.